NEW DELHI: Union Health Minister JP Nadda on Friday highlighted India’s progress in the fight against tuberculosis (TB), stating that the country has recorded a 38 per cent reduction in TB mortality since 2015, surpassing the global decline of 35 per cent, according to the World Health Organisation’s (WHO) Global Tuberculosis Report 2026.
In a post on X, Nadda said the report also highlighted India’s treatment success rate of 94 per cent, attributing the progress to nationwide efforts, technology, community participation and patient-centric healthcare.
“India’s fight against Tuberculosis is showing encouraging results. WHO Global Tuberculosis Report 2026 highlights India’s significant progress, with a 38% reduction in TB mortality since 2015, surpassing the global decline of 35% and a 94% treatment success rate. Under the leadership of Hon’ble PM @narendramodi Ji, our fight against TB has become a nationwide Jan Andolan, powered by technology, community participation and patient-centric care,” he said.
Highlighting the achievements under the TB Mukt Bharat Abhiyaan, the Union Minister shared that more than 25 crore people had been covered under intensified screening.
“Through the TB Mukt Bharat Abhiyaan, over 25 crore people covered under intensified screening, 11 crore+ chest X-rays and 3 crore+ molecular tests conducted, 48.64 lakh TB cases detected, including nearly 15 lakh asymptomatic cases, enabling early treatment,” Nadda said.
He further highlighted the role of technology-driven diagnosis and nutritional support in strengthening TB care across the country.
“From AI-enabled diagnostics to nutritional support under Ni-kshay Poshan Yojana and the dedicated efforts of Ni-kshay Mitras, we are strengthening every aspect of TB care. These achievements reinforce our resolve to ensure that no TB patient is left behind,” he added.
“With Jan Bhagidari and our collective commitment, we will continue moving towards a TB-Mukt Bharat,” he said.
The WHO Global Tuberculosis Report 2026 highlighted India’s 38 per cent reduction in TB mortality since 2015, a decline higher than the global reduction of 35 per cent. India has also recorded a 94 per cent treatment success rate.
WHO on Friday called on countries in the South-East Asia Region to accelerate action to end tuberculosis with stronger political leadership, enhanced domestic investment, expanded access to newer rapid diagnostics and treatment through coordinated action across sectors.
The Region also accounted for around 38% of the global burden of rifampicin-resistant and multidrug-resistant TB, with an estimated 140000 people developing these forms of the disease.
